Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001192482-21-000644
Filing Date
2021-08-05
Accepted
2021-08-05 17:25:52
Documents
1
Period of Report
2021-08-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 5442
  Complete submission text file 0001192482-21-000644.txt   6958
Mailing Address 2292 FARADAY AVENUE CARLSBAD CA 92008
Business Address
KISNER DANIEL L (Reporting) CIK: 0001073407 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37526 | Film No.: 211149643

Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Issuer) CIK: 0001621443 (see all company filings)

EIN.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations